TBPH Competitors & Alternatives
Compare Theravance Biopharma Inc with similar stocks in the same industry
Biotechnology
TBPH
Main Stock$17.03
Tradestie Score
51
Market Cap
$726.21M
P/E Ratio
16.4
Revenue Growth
-0.2%
Analyst Upside
+3.7%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NBTX
Nanobiotix S.A. American Depositary Shares
|
$29.38
|
$903.54M | - | 45 | Compare |
|
ORKA
Oruka Therapeutics, Inc. Common Stock
|
$80.16
|
$900.91M | - | 59 | Compare |
|
GERN
Geron Corp
|
$1.10
|
$899.60M | - | 46 | Compare |
|
ANAB
AnaptysBio, Inc. Common Stock
|
$48.38
|
$894.30M | - | 52 | Compare |
|
TNGX
Tango Therapeutics, Inc.
|
$23.56
|
$887.30M | - | 52 | Compare |
|
ABUS
Arbutus Biopharma Corporation Common Stock
|
$4.20
|
$879.90M | 5.3 | 70 | Compare |
|
PHAT
Phathom Pharmaceuticals, Inc. Common Stock
|
$5.80
|
$871.90M | - | 48 | Compare |
|
DNA
Ginkgo Bioworks Holdings, Inc.
|
$9.83
|
$868.46M | - | 56 | Compare |
|
TSHA
Taysha Gene Therapies, Inc. Common Stock
|
$3.86
|
$867.49M | - | 58 | Compare |
|
FTRE
Fortrea Holdings Inc. Common Stock
|
$23.51
|
$864.42M | - | 31 | Compare |
More TBPH Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry